Skip to main content
. 2010 Apr 26;95(10):1769–1777. doi: 10.3324/haematol.2010.023689

Figure 1.

Figure 1.

Total number of patients (248) treated with EBV-specific CTL, generated by repeated re-stimulations with autologous LCL (lymphoblastoid cell lines), grouped by the most relevant pathologies (PTLD after SOT, PTLD after HSCT, NPC, HD) and by purpose (treatment or prophylaxis). Results obtained with CTL enriched in LMP2 component17 are omitted. Data are inferred by Merlo et al.18 and updated on the basis of recent works.13,19